Profil
Rajan George is the founder of Akshaya Bio, Inc. He currently holds the position of Vice President-Research & Development at ViRexx Medical Corp.
Aktive Positionen von Rajan George
| Unternehmen | Position | Beginn |
|---|---|---|
ViRexx Medical Corp.
 ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - |
Akshaya Bio, Inc.
 Akshaya Bio, Inc. Pharmaceuticals: MajorHealth Technology Akshaya Bio, Inc. develops therapeutics for infectious diseases and cancer. Its technology Chimigen platform to develop therapeutic vaccines for patients with chronic viral infections as well as prophylactic vaccines to prevent infections. The company was founded by Rajan George and is headquartered in Edmonton, Canada. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
ViRexx Medical Corp.
ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Health Technology |
Akshaya Bio, Inc.
Akshaya Bio, Inc. Pharmaceuticals: MajorHealth Technology Akshaya Bio, Inc. develops therapeutics for infectious diseases and cancer. Its technology Chimigen platform to develop therapeutic vaccines for patients with chronic viral infections as well as prophylactic vaccines to prevent infections. The company was founded by Rajan George and is headquartered in Edmonton, Canada. | Health Technology |
